Literature DB >> 2898369

Effect of prednisolone and ketotifen on beta 2-adrenoceptors in asthmatic patients receiving beta 2-bronchodilators.

O E Brodde1, U Howe, S Egerszegi, N Konietzko, M C Michel.   

Abstract

In 13 patients with bronchial asthma, who were on beta 2-adrenergic bronchodilator therapy, the effects of prednisolone and ketotifen on lymphocyte beta 2-adrenoceptor density and -responsiveness were investigated. The mean lymphocyte beta 2-adrenoceptor density and -responsiveness was significantly lower than in healthy controls, presumably due to the long-term beta 2-adrenergic bronchodilator treatment. Both prednisolone 100 mg i.v. and ketotifen 1 mg b.d.p.o. for 6 days rapidly improved lymphocyte beta 2-adrenoceptor function. 16 h after prednisolone and about 6 days after the first dose of ketotifen lymphocyte beta 2-adrenoceptor density and -responsiveness had risen to values within the range in normal volunteers. The improvement of lymphocyte beta 2-adrenoceptor function was accompanied by a significant increase in peak expiratory flow rate before and after inhalation of salbutamol. It is concluded that prednisolone and ketotifen may act beneficially on the recovery of beta 2-adrenoceptor responsiveness to beta 2-adrenergic bronchodilators in tolerant asthmatic patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2898369     DOI: 10.1007/bf00614551

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  34 in total

1.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

Review 2.  Agonist-induced desensitization of the beta-adrenergic receptor-linked adenylate cyclase.

Authors:  T K Harden
Journal:  Pharmacol Rev       Date:  1983-03       Impact factor: 25.468

3.  In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, beta-adrenoceptor agonists and theophylline.

Authors:  R G Goldie; D Spina; P J Henry; K M Lulich; J W Paterson
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

4.  Adverse effects and complications of treatment with beta-adrenergic agonist drugs. Committee on drugs, the American Academy of Allergy and Immunology.

Authors: 
Journal:  J Allergy Clin Immunol       Date:  1985-04       Impact factor: 10.793

5.  Subsensitization of beta-adrenoceptors in airways and lymphocytes of healthy and asthmatic subjects.

Authors:  D P Tashkin; M E Conolly; R I Deutsch; K K Hui; M Littner; P Scarpace; I Abrass
Journal:  Am Rev Respir Dis       Date:  1982-02

6.  High affinity beta-2-adrenergic receptors in mononuclear leucocytes: similar density in young and old normal subjects.

Authors:  R Landmann; H Bittiger; F R Bühler
Journal:  Life Sci       Date:  1981-10-26       Impact factor: 5.037

7.  Spontaneous and provoked resistance to isoproterenol in isolated human bronchi.

Authors:  C Guillot; M Fornaris; M Badier; J Orehek
Journal:  J Allergy Clin Immunol       Date:  1984-11       Impact factor: 10.793

8.  The influence of sex, age, blood pressure and physical stress on beta 2-adrenoceptor density of mononuclear cells.

Authors:  M Middeke; J Remien; H Holzgreve
Journal:  J Hypertens       Date:  1984-06       Impact factor: 4.844

9.  Clinical evaluation of a new orally active anti-anaphylactic compound: ketotifen (HC 20-511) in Japanese adult asthmatics.

Authors:  A Kumagai; H Tomioka; T Shida; T Takahashi; M Muranaka
Journal:  Schweiz Med Wochenschr       Date:  1980-02-09

10.  Ketotifen in adult asthma.

Authors:  A J Dyson; A D Mackay
Journal:  Br Med J       Date:  1980-02-09
View more
  14 in total

Review 1.  Interactions between corticosteroids and beta2-agonists.

Authors:  Robert J Hancox
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

2.  Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients.

Authors:  D M Newnham; A Grove; D G McDevitt; B J Lipworth
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

Review 3.  Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders.

Authors:  S M Grant; K L Goa; A Fitton; E M Sorkin
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

Review 4.  Tolerance with beta 2-adrenoceptor agonists: time for reappraisal.

Authors:  A Grove; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1995-02       Impact factor: 4.335

Review 5.  Asthma medications and their potential adverse effects in the elderly: recommendations for prescribing.

Authors:  D M Newnham
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 6.  Cardiovascular safety of beta(2)-adrenoceptor agonist use in patients with obstructive airway disease: a systematic review.

Authors:  Shelley R Salpeter
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

7.  Parent initiated prednisolone for acute asthma in children of school age: randomised controlled crossover trial.

Authors:  P J Vuillermin; C F Robertson; J B Carlin; S L Brennan; M I Biscan; M South
Journal:  BMJ       Date:  2010-03-01

Review 8.  Benefit-risk assessment of long-acting beta2-agonists in asthma.

Authors:  Catherine M Jackson; Brian Lipworth
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 9.  Risks versus benefits of inhaled beta 2-agonists in the management of asthma.

Authors:  B J Lipworth
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

Review 10.  Inhaled beta 2-adrenoceptor agonists in asthma: help or hindrance?

Authors:  B J Lipworth; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1992-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.